Trump Medicare Plan Targets Drugs From AstraZeneca to Roche

(Bloomberg) -- The latest proposal from the U.S. Centers for Medicare and Medicaid Services (CMS) to let insurers use step therapies, or to drop protections on certain classes of drugs if price inc...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.